Tarsons Products Ltd Stock Price Today (NSE: TARSONS)
Fundamental Score
Tarsons Products Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Tarsons Products Ltd share price today is ₹196.83, up +0.00% on NSE/BSE as of 19 February 2026. Tarsons Products Ltd (TARSONS) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹1.22K (Cr). The 52-week high for TARSONS share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 59.58x, TARSONS is currently trading above its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 4.75% and a debt-to-equity ratio of 0.63.
Tarsons Products Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Tarsons Products Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Tarsons Products Share Price: A Growth Strategist's Financial Analysis
In the dynamic Medical Equipment & Supplies industry, efficient R&D and distribution networks are quickly becoming kingmakers, separating leaders from laggards. This financial analysis examines the Tarsons Products share price (₹219.06) within this context, focusing on key financial metrics to understand its potential for industry dominance. Currently, Tarsons trades at a Price-to-Earnings (PE) ratio of 59.58, suggesting investors have high growth expectations. However, understanding the underlying profitability and efficiency is crucial to assess whether these expectations are justified.
A critical metric in assessing Tarsons' long-term viability is its Return on Capital Employed (ROCE), which currently sits at 6.91%. This relatively low ROCE raises concerns about the company's ability to generate substantial returns from its invested capital. A higher ROCE typically indicates a wider economic moat, making it difficult for competitors to erode market share and pricing power. The current ROCE suggests that Tarsons' moat, if it exists, may be relatively narrow and vulnerable to competitive pressures.
When comparing Tarsons Products Ltd with peers, such as
Choksi Asia, differences in management quality can significantly impact shareholder value. While quantitative data offers valuable insights, qualitative factors like management's strategic vision, execution capabilities, and track record of capital allocation should be examined. Further investigation into Choksi Asia's operational strategy could help contextualize Tarsons' competitive positioning.Ultimately, the 6.91% ROCE directly impacts Tarsons' ability to reinvest profits at attractive rates, limiting its capacity to fuel future growth and strengthen its competitive advantage. This analysis is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra and utilizes publicly available information and observational data. It is for informational purposes only and should not be construed as financial advice. This analysis focuses on observed trends and calculated metrics and does not offer any buy/sell recommendations related to Tarsons Products shares.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Tarsons Products Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of TARSONS across key market metrics for learning purposes.
Positive Indicators
1 factors identified
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Below-Average Return on Equity (4.75%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (6.91%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 59.58x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-67.74%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Limited Institutional Interest (FII+DII: 5.90%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Tarsons Products Ltd Financial Statements
Comprehensive financial data for Tarsons Products Ltd including income statement, balance sheet and cash flow
About TARSONS (Tarsons Products Ltd)
Tarsons Products Ltd (TARSONS) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Medical Equipment & Supplies sector with a current market capitalisation of ₹1.22K (Cr). Tarsons Products Ltd has delivered a Return on Equity (ROE) of 4.75% and a ROCE of 6.91%. The debt-to-equity ratio stands at 0.63, reflecting the company's capital structure. Investors tracking TARSONS share price can monitor key metrics including P/E ratio, promoter holding of 47.31%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
Latest News
TARSONS Share Price: Frequently Asked Questions
What is the current share price of Tarsons Products Ltd (TARSONS)?
As of 19 Feb 2026, 07:34 am IST, Tarsons Products Ltd share price is ₹196.83. The TARSONS stock has a market capitalisation of ₹1.22K (Cr) on NSE/BSE.
Is TARSONS share price Overvalued or Undervalued?
TARSONS share price is currently trading at a P/E ratio of 59.58x, compared to the industry average of 47.87x. Based on this relative valuation, the Tarsons Products Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of TARSONS share price?
The 52-week high of TARSONS share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Tarsons Products Ltd share price?
Key factors influencing TARSONS share price include quarterly earnings growth (Sales Growth: 3.10%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Tarsons Products Ltd a good stock for long-term investment?
Tarsons Products Ltd shows a 5-year Profit Growth of N/A% and an ROE of 4.75%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.63 before investing in TARSONS shares.
How does Tarsons Products Ltd compare with its industry peers?
Tarsons Products Ltd competes with major peers in the Medical Equipment & Supplies. Investors should compare TARSONS share price P/E of 59.58x and ROE of 4.75% against the industry averages to determine competitive standing.
What is the P/E ratio of TARSONS and what does it mean?
TARSONS share price has a P/E ratio of 59.58x compared to the industry average of 47.87x. Investors pay ₹60 for every ₹1 of annual earnings.
How is TARSONS performing according to Bull Run's analysis?
TARSONS has a Bull Run fundamental score of 13.8/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does TARSONS belong to?
TARSONS operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting Tarsons Products Ltd share price.
What is Return on Equity (ROE) and why is it important for TARSONS?
TARSONS has an ROE of 4.75%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Tarsons Products Ltd generates profits from shareholders capital.
How is TARSONS debt-to-equity ratio and what does it indicate?
TARSONS has a debt-to-equity ratio of 0.63, which indicates moderate leverage that should be monitored.
What is TARSONS dividend yield and is it a good dividend stock?
TARSONS offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Tarsons Products Ltd shares.
How has TARSONS share price grown over the past 5 years?
TARSONS has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in TARSONS and why does it matter?
Promoters hold 47.31% of TARSONS shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Tarsons Products Ltd.
What is TARSONS market capitalisation category?
TARSONS has a market capitalisation of ₹1225 crores, placing it in the Small-cap category.
How volatile is TARSONS stock?
TARSONS has a beta of N/A. A beta > 1 suggests the Tarsons Products Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is TARSONS operating profit margin trend?
TARSONS has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is TARSONS quarterly performance?
Recent quarterly performance shows Tarsons Products Ltd YoY Sales Growth of 3.10% and YoY Profit Growth of -67.74%.
What is the institutional holding pattern in TARSONS?
TARSONS has FII holding of 5.82% and DII holding of 0.08%. Significant institutional holding often suggests professional confidence in the Tarsons Products Ltd stock.